← Back to Search

Neuromodulation Device

NEUROMARK System for Chronic Rhinitis

N/A

Waitlist Available

Research Sponsored by Neurent Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial is testing a new device to treat chronic rhinitis (a runny nose that doesn't go away). The device is called the NEUROMARK System, and it's made by Neurent Medical. This study will look at how safe and effective the device is in treating chronic rhinitis.

Eligible Conditions

Chronic Rhinitis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Efficacy

Safety

Trial Design

1Treatment groups

Experimental Treatment

Group I: Experimental: TreatmentExperimental Treatment1 Intervention

Subjects will undergo treatment with the NEUROMARK System

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

NEUROMARK System

2022

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Neurent MedicalLead Sponsor

4 Previous Clinical Trials

505 Total Patients Enrolled

4 Trials studying Chronic Rhinitis

505 Patients Enrolled for Chronic Rhinitis

Annalise SorensenStudy DirectorNeurent Medical

3 Previous Clinical Trials

373 Total Patients Enrolled

3 Trials studying Chronic Rhinitis

373 Patients Enrolled for Chronic Rhinitis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many venues are the research team utilizing for this experiment?

"This investigation is currently taking place in 4 distinct locales, such as Bethlehem, Puyallup and Birmingham. To minimize travel needs when enrolling, it would be prudent to pick the research facility that is closest to you."

Answered by AI

Is enrollment still available for those wanting to participate in this experiment?

"Clinicaltrials.gov reveals that this trial is no longer enrolling participants; the original posting was on March 14th 2022, with a subsequent update on October 27th 2022. Fortunately, there are 62 other trials actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

2022. "Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05324397.